PatrickMDillonMD

Oncology • Charlottesville, VA

Associate Professor of Oncology, University of Virginia School of Medicine

Join to view full profile

Dr. Dillon is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Dillon's full profile

Already have an account?

Office
1240 Lee St
Charlottesville, VA 22908
Phone+1 434-924-9333

Fax+1 434-244-7526
Is this information wrong?

Education & Training

University of North Carolina HospitalsFellowship, Hematology and Medical Oncology, 2007 - 2010
University of Virginia Medical CenterResidency, Internal Medicine, 2004 - 2007
University of North Carolina at Chapel Hill School of MedicineClass of 2004

Certifications & Licensure

VA State Medical License 2004 - 2024
NC State Medical License 2007 - 2022
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2012

Clinical Trials

Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer Start of enrollment: 2008 Oct 13
Completed
Phase 3
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3
Study of Dovitinib (TKI258) in Adenoid Cystic Carcinoma Start of enrollment: 2012 Mar 01
Completed
Phase 2
Pilot Study of a Breast Cancer Vaccine Plus Poly-ICLC for Breast Cancer Start of enrollment: 2012 Jul 01
Terminated
Phase 1
A Phase II Study of Everolimus in Combination With Exemestane Versus Everolimus Alone Versus Capecitabine in Advance Breast Cancer. Start of enrollment: 2013 Feb 26
Completed
Phase 2
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer Start of enrollment: 2013 Feb 01
Completed
Phase 2
Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Gemcitabine and Carboplatin in Metastatic Triple Negative Breast Cancer (mTNBC) Start of enrollment: 2017 Feb 02
Terminated
Phase 2
Focused Ultrasound and Pembrolizumab in Metastatic Breast Cancer Start of enrollment: 2017 Sep 25
Terminated
Phase 1
A Pilot Study of the Combination of Entinostat With Capecitabine in High Risk Breast Cancer After Neo-adjuvant Therapy Start of enrollment: 2019 Jan 29
Completed
Phase 1
Testing the Addition of Radium Therapy (Radium-223 Dichloride) to the Usual Chemotherapy Treatment (Paclitaxel) for Advanced Breast Cancer That Has Spread to the Bones Start of enrollment: 2020 Aug 04
Recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

Applications of the partial-order continual reassessment method in the early development of treatment combinations.
Nolan A Wages, Craig L Slingluff Jr, Gina R Petroni, Patrick M Dillon, Craig A Portell> ;Clinical Trials. 2024 Mar 30
Phase I study targeting newly diagnosed grade 4 astrocytoma with bispecific antibody armed T cells (EGFR BATs) in combination with radiation and temozolomide.
Thakur, A., Kim, J., Kassay-McAllister, J., Schalk, D., Lopes, M., Liu, Q., Fadul, C., Donahue, J., Purow, B., Dillon, P., Le, T., Schiff, D., Lum, L.> ;Journal of Neuro-Oncology. 2024 Jan 1
Slimmer's Palsy Following Weight Loss Associated With Metastatic Breast Cancer: A Case Report.
Collis, R., Gee, A., Dillon, P., Warwick, M.> ;Cureus. 2024 Jan 1
A Pilot Study of the Combination of Entinostat with Capecitabine in Advanced Breast Cancer.
Humphrey, C., Petroni, G., Wages, N., Millard, T., Brenin, C., Dhakal, A., Falkson, C., Dillon, P.> ;International Journal of Breast Cancer. 2024 Jan 1
1 citations
Estrogen receptor positive breast cancer: contemporary nuances to sequencing therapy.
Jenna Schlefman, Christiana Brenin, Trish Millard, Patrick Dillon> ;Medical Oncology. 2023 Dec 16
3 citations
Complete Response of Triple-Negative Metaplastic Carcinoma of the Breast Using Pembrolizumab.
Amrita Ladwa, Omar Elghawy, Anneke Schroen, Kristan Abernathy, Jenna Schlefman, Patrick Dillon> ;Case Reports in Oncology. 2023 Oct 16
4 citations
Systematic review of the management of brain metastases from hormone receptor positive breast cancer.
Shirley Jusino, Camilo E Fadul, Patrick Dillon> ;Journal of Neuro-Oncology. 2023 Mar 1
1 citations
Desmoid Tumor and Implant-Based Breast Reconstruction.
Catherine Kilmartin, Clinton Westover, Shyam Raghavan, Patrick M Dillon, Chris A Campbell> ;Case Reports in Oncology. 2023 Feb 14
3 citations
Replicative Instability Drives Cancer Progression.
Benjamin B Morris, Jason P Smith, Qi Zhang, Zhijie Jiang, Oliver A Hampton, Michelle L Churchman, Susanne M Arnold, Dwight H Owen, Jhanelle E Gray, Patrick M Dillon, H...> ;Biomolecules. 2022 Oct 26
147 citations
Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Nega...
Francois-Clement Bidard, Virginia G Kaklamani, Patrick Neven, Guillermo Streich, Alberto J Montero, Frédéric Forget, Marie-Ange Mouret-Reynier, Joo Hyuk Sohn, Donatien...> ;Journal of Clinical Oncology. 2022 Oct 1
3 citations
A Rare Case of Large-Vessel Vasculitis following Checkpoint Inhibitor Therapy and Pegfilgrastim.
Joseph Mort, Shipra Maheshwari, Nayanika Basu, Patrick Dillon, Kevin Brady, Harry Bear, Trish Millard> ;Case Reports in Oncological Medicine. 2022 Jan 1
4 citations
Platinum Chemotherapy Induces Lymphangiogenesis in Cancerous and Healthy Tissues That Can be Prevented With Adjuvant Anti-VEGFR3 Therapy.
Alexandra R Harris, Savieay Esparza, Mohammad S Azimi, Robert Cornelison, Francesca N Azar, Danielle C Llaneza, Maura Belanger, Alexander Mathew, Svyatoslav Tkachenko,...> ;Frontiers in Oncology. 2022 Jan 1
9 citations
Bispecific antibodies for the treatment of breast cancer.
Patrick M. Dillon, Jogender Tushir-Singh, Lawrence G Lum> ;Expert Opinion on Biological Therapy. 2021 May 9
19 citations
Effect of Taxane Chemotherapy With or Without Indoximod in Metastatic Breast Cancer: A Randomized Clinical Trial.
Veronica Mariotti, Hyo S. Han, Roohi Ismail-Khan, Shou-Ching Tang, Patrick M. Dillon, Alberto J. Montero, Andrew Poklepovic, Susan A. Melin, Nuhad K. Ibrahim, Eugene P...> ;JAMA Oncology. 2021 Jan 1
14 citations
Severe combined cardiac and neuromuscular toxicity from immune checkpoint blockade: an institutional case series
Puja C. Arora, Laura Talamo, Patrick M. Dillon, Ryan D. Gentzler, Trish A Millard, Michael Salerno, Craig L. Slingluff, Elizabeth M. Gaughan> ;Cardio-Oncology. 2020 Sep 23
5 citations
Genesis of Quality Measurements to Improve the Care Delivered to Patients With Brain Metastases.
Julio Silvestre, Tracey Gosse, Paul W. Read, Ryan D. Gentzler, Benjamin Purow, Ashok R. Asthagiri, Elizabeth Gaughan, Patrick M. Dillon, James M. Larner, Roger T. Ande...> ;JCO Oncology Practice. 2021 Mar 1
9 citations
Evaluating Nelipepimut-S in the Treatment of Breast Cancer: A Short Report on the Emerging Data
Patrick M. Dillon, Christiana Brenin, Craig L. Slingluff> ;Breast Cancer. 2020 Apr 3
3 citations
Efficient dose-finding for drug combination studies involving a shift in study populations
Nolan A. Wages, Trish A Millard, Patrick M. Dillon, Christiana Brenin, Gina R. Petroni> ;Contemporary Clinical Trials Communications. 2020 Jan 7
6 citations
Radiographically Occult Carcinomatous Spread of Breast Cancer to the Liver: A Challenging Case.
Trish A Millard, Akriti Gupta, Christiana Brenin, Paul Marshall, Patrick M. Dillon> ;Case Reports in Oncological Medicine. 2019 Dec 6
243 citations
Open-label Clinical Trial of Niraparib Combined With Pembrolizumab for Treatment of Advanced or Metastatic Triple-Negative Breast Cancer.
Shaveta Vinayak, Sara M. Tolaney, Lee S. Schwartzberg, Monica M. Mita, Georgia A. McCann, Antoinette R. Tan, Andrea E. Wahner-Hendrickson, Andres Forero, Carey K. Ande...> ;JAMA Oncology. 2019 Jun 13
4 citations
Cases and evidence for panel testing in cancer genetics: Is site‐specific testing dead?
Martha H. Thomas, Lydia K. Higgs, Susan C. Modesitt, Anneke T. Schroen, Kari L. Ring, Patrick M. Dillon> ;Journal of Genetic Counseling. 2019 Jun 1
37 citations
LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases.
Amanda E.D. Van Swearingen, Marni B. Siegel, Allison M. Deal, Maria J. Sambade, Alan P. Hoyle, D. Neil Hayes, Heejoon Jo, Paul Little, Elizabeth Claire Dees, Hyman B. ...> ;Breast Cancer Research and Treatment. 2018 Jun 25
58 citations
IDO expression in breast cancer: an assessment of 281 primary and metastatic cases with comparison to PD-L1.
Erik A. Dill, Patrick M. Dillon, Timothy N. J. Bullock, Anne M. Mills> ;Modern Pathology. 2018 May 25
51 citations
The Relationship Between Mismatch Repair Deficiency and PD-L1 Expression in Breast Carcinoma.
Anne M. Mills, Erik A. Dill, Christopher A. Moskaluk, Jaroslaw Dziegielewski, Timothy N. J. Bullock, Patrick M. Dillon> ;The American Journal of Surgical Pathology. 2018 Feb 1
2 citations
CONCORD biomarker prediction for novel drug introduction to different cancer types.
Young-Chul Kim, Patrick M. Dillon, Taesung Park, Jae K. Lee> ;Oncotarget. 2018 Jan 2
Join now to see all

Press Mentions

Theraclion Announces First Patient Inclusion in Early-Stage Breast Cancer StudyMarch 9th, 2022
UVA Cancer Center to Expand Use of Theraclion’s HIFU System in Cancer Treatment ResearchJune 1st, 2021
Focused Ultrasound Symposium Showcases Latest Advances in Noninvasive Therapy for Brain Disorders, Cancer and Other Major DiseasesOctober 31st, 2018
Join now to see all